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Abstract 17 
The effect of soy isoflavones on the Maillard reaction (MR) was investigated. Model 18 
systems composed of the soy protein glycinin (10 mg mL
-1
) and fructose (40 mg mL
-1
) 19 
under basic pH conditions were employed for testing the anti-glycative effect of the 20 
major antioxidant soy isoflavones (genistin and genistein) and a soy isoflavone-rich 21 
extract. The progress of MR was estimated by analysis of free amino groups; sugar 22 
covalently bound to protein, protein-bound N
ε
-(carboxymethyl)lysine (CML) and 23 
fluorescence spectra. Genistin (10 µg mL
-1
, 23 µM) and its metabolite genistein (10 µg 24 
mL
-1
, 37 µM) did not prevent protein glycation. The soy isoflavone-rich extract (5 mg 25 
mL
-1
) efficiently decreased bound of sugar to the protein skeleton (20%) and formation 26 
of advanced glycation end products (AGEs) (> 80%). The anti-glycative mechanism of 27 
isoflavones may be related to its conjugation to glycation sites of the protein structure 28 
(free amino groups), their antioxidant character and trapping of dicarbonyl 29 
intermediates. Extracts based on mixtures of isoflavones may be useful for producing 30 
glycated conjugates avoiding the substantial formation of AGEs bound to protein. 31 
32 
Page 2 of 23Food & Function
 3
Introduction 33 
Glycation, also known as Maillard reaction (MR), is a non-enzymatic reaction between 34 
carbonyl groups of reducing sugar and free amino groups of proteins. Non-oxidative 35 
and/or oxidative modifications of the early MR products (Amadori and Heyns products) 36 
result in the formation of a variety of advanced glycation endproducts (AGEs). AGEs 37 
can be fluorescent crosslinked structures such as pentosidine, or non-fluorescent 38 




. AGEs are formed in foods and in 39 
the human body and they are considered to be undesirable compounds
2
. The search for 40 
natural inhibitors of AGEs formation is of great interest and a priority research line
3-4
. 41 
Compounds with antioxidant properties may be powerful inhibitors of the formation of 42 
AGEs. 43 
Soy isoflavones are phytochemicals that exist in two chemical forms, glucosidic 44 
conjugates (daidzin, genistin, and glycitin), and the unconjugated forms, or aglycones 45 
(daidzein, genistein, and glycitein)
5
. Isoflavones are powerful natural antioxidants
6
. In a 46 
previous study, the relationship between the effect on AGEs formation and radical 47 
scavenging activity of 62 flavonoids, including 7 isoflavones (diadzein, diadzin, 48 
genistein, genistin, tectoridin, puerarin and biochanin), was examined
7
. AGEs formation 49 
was assessed solely by measuring characteristic fluorescence at an excitation 50 
wavelength of 370 nm and an emission wavelength of 440 nm. Soy isoflavones (at 200 51 
µM) inhibited formation of fluorescent AGEs either completely (daidzin) or by 12-34% 52 
(daidzein, genistein, genistin). To the best of our knowledge no previous studies 53 
regarding the inhibitory effect of soy isoflavones on the formation of non-fluorescent 54 
AGEs, such as CML, have been published. 55 
Formation of MRPs derived from the interaction of soy proteins and fructose 56 
may be inhibited by isoflavones. As a consequence, isoflavones may be used to form 57 
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particular glycoconjugates with specific and improved functional properties. Other 58 
phytochemicals, such as ferulic acid, have been successfully used to achieve this aim
8
. 59 
The present work aimed to gain new knowledge on the anti-glycation capacity of 60 
soy isoflavones (pure and soy isoflavone-rich extract) and their potential for the 61 
formation of glycoconjugates avoiding tedious and high cost purification processes for 62 
removing contaminants (AGEs and unreactive fructose and proteins). Fructose is 63 
commonly used as a sweetener in processed foods and beverages, such as soy milk
9-10
. 64 
Nowadays, soy based foods are very popular because their health promoting properties, 65 




. Therefore, their 66 
presence as contaminants in glycoconjugates preparations is not considered a 67 
disadvantage. On the under hand, glycation reduces soy protein immnureactivity
13
. The 68 
effect of soy isoflavones on the formation of early MRPs and AGEs, both fluorescent 69 
and non-fluorescent (CML), in reaction mixtures composed by soy proteins and fructose 70 
under basic conditions was investigated. A high pH of reaction was used to enhance the 71 
solubility of soy proteins and to catalyse the advanced stages of the MR. 72 
 73 
Materials and methods 74 
Materials 75 
All chemicals and solvents were of analytical grade. Fructose, genistin, genistein, 76 
lysine, N
α
-acetyl-L-lysine, nonafluoropentanoic acid (NFPA), phenol, sodium bisulfite, 77 
sodium borohydride, sodium dodecyl sulfate (SDS), and trifluoroacetic acid (TFA) were 78 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Biuret reagent, Folin-Ciocalteu's 79 
phenol reagent, hydrochloric acid 37% (HCl), methanol, sodium hydroxide (NaOH), 80 
sulfuric acid 96%, potassium hydroxide (KOH), and trichloroacetic acid (TCA) were 81 
purchased from Panreac Química S.A. (Barcelona, Spain). Other chemicals and their 82 
Page 4 of 23Food & Function
 5
suppliers were as follows: β-mercaptoethanol (Merck, Hohenbrunn, Germany), 83 
acetonitrile HPLC grade (ACN) (Chromanorm, Leuven, Belgium), CML (NeoMPS, 84 
Strasbourg, France), d4-lysine (Cambridge Isotopes, Andover, MA, USA), o-85 
phthaldialdehyde (OPA) (Fluka, Buchs, Switzerland), and sodium tetraborate (Acros-86 
Organics, Geel, Belgium). d4-CML was kindly provided by Professor S.R. Thorpe 87 
(Department of Chemistry and Biochemistry, University of South Carolina, SC, USA). 88 
Microtest 96-well plates were purchased from Sarstedt AG & Co. (Nümbrecht, 89 
Germany). The Amicon® Ultra-4 centrifugal filter unit fitted with an Ultracel-50 90 
cellulose membrane (50 kDa cut-off) were from Millipore Co. (Billerica, MA, USA). 91 
Soybean flour (from organically grown; 35% protein, 3.1% carbohydrates, and 18% fat) 92 
and commercial isoflavone preparation (capsules active of ethanolic extract 117.85 mg 93 
60% v/v dry hypocotyls Glycine max (L) Merr. (Soybean) containing 30% of total 94 
isoflavones) were purchased from a local supermarket in Spain. 95 
 96 
Isolation of soy glycinin protein 97 
Soy glycinin was extracted from defatted soy flour as described by Wu et al
14
. Briefly, 98 
defatted soybean flour (150 mg) was resuspended in deionized water, 1:15 (w/v), the pH 99 
was adjusted to 7.5 with 2 M NaOH, and the resulting slurry was mechanically stirred 100 
for 1 hour at room temperature. After centrifugation at 14,250g for 30 min at 20ºC, the 101 
insoluble residue was discarded. Sodium bisulfite was added to the supernatant to 102 
achieve a final concentration of 10 mM of SO2 (0.98 g L
-1
). Glycinin was precipitated 103 
by decreasing the pH to 6.4 with 2 M HCl and incubating at 4ºC overnight. Then the 104 
protein solution was centrifuged at 7,500g for 20 min at 4ºC. The precipitated glycinin 105 
was resuspended in deionized water, freeze-dried and stored at -20ºC until use. 106 
 107 
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Preparation of soy isoflavone-rich extract 108 
The commercial preparation containing a mixture of daidzein, glycitein and genistein 109 
(600 mg) was dissolved in 10 mL of reaction medium (0.2% KOH solution) and stirred 110 
for 1 hour at room temperature. The preparation was centrifuged at 4,000g for 15 min 111 
and the supernatant (soluble fraction) was collected. Finally, the concentration of 112 
soluble isoflavones was estimated by the Folin-Ciocalteu micromethod assay
15
 using 113 
genistein (0.5-5 mg mL
-1
) for obtaining the calibration curve. All measurements were 114 
performed in triplicate. 115 
 116 
Model system preparation 117 
To prepare the glycated model systems, soy glycinin (10 mg mL
-1
) was mixed with 118 
genistin (10 µg mL
-1
), genistein (10 µg mL
-1
) or soy isoflavone-rich extract (5 mg mL
-1
) 119 
in 0.2% KOH solution (pH 12) and pre-incubated for 1 h or 16 h at 60°C. Fructose (40 120 
mg mL
-1
) was then added and incubation continued for a further hour. Glycation was 121 
stopped by cooling the samples on ice. The pH of the model glycation systems at the 122 
beginning and end of the reaction was 12. Some samples were also prepared in the 123 
absence of fructose. All samples were prepared in triplicate. 124 
 125 
Sample fractionation 126 
Incubated samples were fractionated by ultrafiltration in order to recover unmodified 127 
and glycated proteins for further analysis. Briefly, sample (2 mL) was placed in the 128 
sample reservoir of an Amicon
®
 Ultra-4 centrifugal filter unit fitted with an Ultracel-50 129 
cellulose membrane (50 kDa cut-off) and centrifuged at 7,500g for 20 min at room 130 
temperature. The filters were washed with distilled water (4 mL). The concentrated 131 
samples were recovered, dissolved in water (2 mL) and stored at -20ºC until analysis. 132 
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Recovery of protein (RMM > 50 kDa) was determined by the Biuret method in 133 
microplate format. Free amino groups, incorporation of sugar into the protein backbone, 134 
CML, and fluorescecent AGEs were determined as described below. 135 
 136 
Determination of free amino groups: available lysine 137 
Free amino groups of samples were determined by the o-phthalaldehyde (OPA) 138 
method
16
. OPA reagent was prepared fresh before use by mixing 0.1 M sodium 139 
tetraborate (pH 9.5, 50 mL), 20% (w/v) SDS (5 mL), β-mercaptoethanol (0.2 mL) and 140 
OPA (80 mg dissolved in 2 mL of  methanol), and adjusting the final volume to 100 mL 141 
with distilled water. An aliquot of protein solution containing 25 µg protein was mixed 142 
with OPA reagent (3 mL). After incubation for 5 min at room temperature, the 143 
fluorescence was read against a blank containing the OPA reagent using a Shimadzu 144 
spectrofluorometer RF-1501 (Shimadzu Co., Kyoto, Japan). The wavelength of 145 
maximum excitation was 340 nm and the wavelength of maximum emission was 455 146 
nm. Calibration curves were constructed using standard solutions of N
α
-acetyl-L-lysine 147 
(10-1000 µM). All measurements were performed in triplicate and data were expressed 148 
as a % of free amino groups. Untreated glycinin (control) was assumed to have 100% 149 
amino groups available. 150 
 151 
Estimation of carbohydrate covalently bound to the protein backbone 152 
Carbohydrate bound to the protein backbone was analysed by the phenol-sulfuric acid 153 
method in microplate format
17
. An appropriate dilution of sample (100 µL) was pipetted 154 
into a glass vial, to which was added concentrated sulfuric acid (300 µL) and 5% phenol 155 
in water (60 µL). After incubating at 90ºC for 5 min, samples were cooled to room 156 
temperature for 5 min. Finally, 200 µL aliquots were placed in the wells of a 96-well 157 
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microplate and the absorbance was measured at 490 nm by employing a microplate 158 
reader BioTek PowerWave
TM
 XS (BioTek Instruments, Inc., Winooski, VT, USA). A 159 
calibration curve of fructose (5-40 µg per well) was constructed and employed for 160 
quantification. Data were expressed as µg of fructose/100 mg of protein. All 161 
measurements were performed in triplicate. 162 
 163 
CML analysis 164 
Protein-bound CML was determined by ultra-performance liquid chromatography 165 
(UPLC)-MS/MS according to the procedure recently described by Assar et al
18
. Prior to 166 
analysis, samples were reduced with sodium borohydride, protein was isolated by TCA 167 
precipitation and hydrolysed with 6M HCl. The protein hydrolyzate was purified by 168 
solid phase extraction prior to CML analysis by UPLC-MS/MS. Samples were analysed 169 
in triplicate. 170 
 171 
Fluorescence measurement 172 
Fluorescent protein-bound AGEs were measured as previously reported by Wang et 173 
al.
19
 by measuring the fluorescence intensity of samples using an excitation wavelength 174 
of 337 nm and emission wavelengths ranging from 350 nm to 550 nm with a Shimadzu 175 
spectrofluorometer RF-1501 (Shimadzu Co., Kyoto, Japan). Glycinin samples at a 176 
concentration of 10 mg mL
-1
 in distilled water were positioned in a cuvette of 1 cm path 177 
length. All emission spectra were recorded at 0.5 nm wavelengths intervals. 178 
 179 
Statistical analysis 180 
Data are expressed as the mean ± standard deviation (SD) of triplicates from three 181 
independent experiments and analysed by IBM SPSS version 21.0 (SPSS Inc., Chicago, 182 
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IL, USA). Analysis of variance was performed using ANOVA procedures. Significant 183 




The loss of available primary amino groups is an indicator used to estimate the extent of 188 
the MR
20
. Fig. 1 shows amino groups availability obtained by OPA assay. The 189 
percentage of available amino groups in all samples was determined as the relative 190 
difference between the percentage of reactive amino groups in the unheated soy glycinin 191 
protein sample and that in the glycated models. Heating of soy glycinin protein (heated 192 
control) did not significantly (p > 0.05) affect the availability of free amino groups. A 193 
significant decrease (p < 0.05) in free amino groups availability of soy glycinin protein 194 
was observed by heating in presence of fructose (glycation model system) suggesting 195 
the occurrence of the MR. Values of availability of free amino groups in the samples 196 
containing the soy isoflavone-rich extract and glycation model system did not 197 
significantly differ (p > 0.05). Interestingly, the addition of pure genistin and genistein 198 
together with fructose caused a significant decrease in free amino groups’ availability (p 199 
< 0.05). 200 
Monitoring sugar conjugation to protein allows evaluation of the degree of 201 
formation of the earliest MRPs
21
. Sugar conjugation was detected by the phenol-sulfuric 202 
acid method. As shown in Fig. 2, fructose was successfully bound to soy glycinin 203 
protein (glycation model system) indicating the formation of early MRPs (Heyns 204 
compounds) (p < 0.05). As expected, controls (unheated soy glycinin and protein heated 205 
in absence of fructose) proved that reactivity could not be attributed to possible release 206 
of carbonyl functions from the protein. Similar levels of early MRPs were formed in the 207 
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inhibition model systems containing genistin and genistein and the glycation model 208 
system (absence of isoflavones). The content of protein-bound early MRPs was 209 
significantly (p < 0.05) lower (20%) in samples treated with isoflavone extract 210 
compared to that found in the sample corresponding to positive control of the Maillard 211 
reaction (glycation model). 212 
CML, a non-fluorescent AGE, is an important specific biomarker that increases 213 
during the MR and correlates with the severity of the reaction. We evaluated whether 214 
isoflavones could inhibit CML formation during soy glycinin glycation by fructose. Fig. 215 
3 shows the effect of genistin, genistein and soy isoflavone-rich extract on protein-216 
bound CML formation. CML was readily formed under the experimental control 217 
conditions (soy glycinin/fructose) and in the presence of genistin and genistein, but its 218 
generation was significantly inhibited (p < 0.05) by 87% and 92% in glycation models 219 
treated with the soy isoflavone-rich extract for 1 and 16 hours, respectively. The level of 220 
CML inhibition was greater than that observed for the formation of early MRPs (20%). 221 
This is a novel result. 222 
Fig. 4 illustrates the effect of genistin, genistein and soy isoflavone-rich extract 223 
on the formation of fluorescent AGEs. The fluorescence spectrum of glycinin treated 224 
with carbohydrate and isoflavones showed modifications with respect to the control and 225 
heated glycinin spectrum. Glycinin reaction with fructose caused formation of 226 
fluorescent compounds with emission maxima between 420-425 nm and intensity of 227 
70.1 arbitrary units of fluorescence. The addition of genistin and genistein in the 228 
reaction mixtures did not inhibit the formation of fluorescence compounds, identical 229 
spectra to that obtained for the glycation control being observed. These results support 230 
the lack of inhibitory activity in the formation of AGEs at naturally occurring 231 
concentrations of these compounds in soy proteins. The addition of the soy isoflavone-232 
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rich extract inhibited fluorescence formation. The resulting emission spectrum showed a 233 
maximum at 470 nm with an intensity of 15.8 arbitrary units of fluorescence. This 234 
intensity value was similar to that detected for the unheated and heated protein; 235 
however, the shape of the spectra of these samples differed. 236 
 237 
Discussion 238 
Results on availability of free amino groups (Fig. 1) and level of sugar bound to the 239 
proteins (Fig. 2) suggest that the MR is the major chemical reaction involving free 240 
amino groups of the protein polypeptide chain in the model systems. Although other 241 
reactions, e.g., cross-linking of proteins, may also decrease the level of free amino 242 
groups, no evidence was obtained for such chemical events being important under our 243 
experimental conditions. Pure isoflavones (genistin and genistein) at the concentrations 244 
tested in the present research did not significantly inhibit the progress of the Maillard 245 
reaction (Fig. 2-4). However, the soy isoflavone-rich extract (composed of a mixture of 246 
soy isoflavones) significantly decreased the formation of early MR products (Fig. 2) and 247 
also the progress of the reaction to the advanced stage. Thus, the formation of both non-248 
fluorescent (CML) (Fig. 3) and fluorescent AGEs (Fig. 4) was significantly inhibited. 249 
 In the present study, the availability of free amino groups on soy glycinin protein 250 
was reduced in all glycation models at 60°C (Fig. 1). This suggests that amino groups 251 
on soy glycinin were progressively bound to the carbonyl moiety of fructose and/or 252 
isoflavones. In addition, lower levels (20%) of sugar bound to the protein were found in 253 
samples treated with the isoflavone enriched extract compared to the glycation control 254 
or samples containing the pure isoflavones. These data suggest that isoflavones are able 255 
to decrease the reactivity of amino groups on the soy glycinin with fructose molecules 256 
in the reaction mixture during the early steps of the MR. In addition, our findings seem 257 
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to indicate the possible reaction of phenolic compounds with soy glycinin and 258 
consequent formation of glycinin-isoflavone complexes.   Although the mechanisms of 259 
inhibition by polyphenolic compounds of glycation are not completely understood, it is 260 
possible that some of these natural compounds bind to protein inhibiting Amadori 261 
product generation and subsequent AGEs formation
22
. Further analysis employing 262 
advanced analytical tools for the identification of the novel structures is needed to 263 
confirm this hypothesis. 264 
 Several in vivo and in vitro studies have indicated that dietary phenolic 265 
compounds could inhibit the formation of AGEs
7,8,23
. The inhibitory effects of flavonoid 266 
compounds on AGEs formation are mainly thought to involve their potent antioxidant 267 
activity, leading to scavenging of free radicals formed during glycation, and thus 268 
inhibiting the subsequent formation of AGEs. However, limited effort has been devoted 269 
to understanding the underlying mechanisms of action of effective natural AGE 270 
inhibitors. To inhibit AGEs formation, anti-AGE agents, such as flavonoids, may act 271 
through different mechanisms. 272 
 Reactive dicarbonyl intermediates, such as MGO, play an important role in the 273 
chemistry of AGEs formation. Wu et al.
24
 found that protein co-incubated with 274 
genistein and MGO could inhibit MGO-induced reactive oxygen species. Lv et al.
25
 275 
have hypothesized that dietary flavonoids such as genistein can inhibit the formation of 276 
AGEs by trapping reactive dicarbonyl intermediates under neutral and alkaline 277 
conditions in vitro. Dicarbonyl intermediates may be produced by degradation of 278 
fructose. Our data for sugar bound to protein also suggest a major formation of early 279 
Maillard reaction products in all samples containing fructose (Fig. 2). In agreement, the 280 
trapping of dicarbonyl intermediate seems to be not the only anti-AGEs pathway by 281 
which the isoflavones enriched extract operates. 282 
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 It has been proposed that no oxidation reaction is involved in the formation of 283 
Amadori or Heyns rearrangement products, whereas oxidation plays a role in the 284 
formation of AGEs. Flavonoids with antioxidant properties, such isoflavones, may 285 
protect against glycation-derived free-radical-mediated oxidation by acting as transition 286 
metal ion chelators, and preventing the self-oxidation of reducing sugars, Amadori 287 
products and reactive carbonyl species
26
. It has been reported by Jang et al.
27
 that 288 
daidzein and genistein isoflavones, obtained from P. lobata root extracts, possess 289 
significant inhibitory activity against fluorescent AGE formation with IC50 values of 290 
12.0 µg mL
-1
 and 70.1 µg mL
-1
, respectively. We found no anti-AGEs activity with 291 
genistin and genistein at 10 µg mL
-1
 concentration; however, the soy isoflavone-rich 292 
extract containing a mixture of different isoflavones at higher concentration (5 mg mL
-1
) 293 
was an effective anti-glycation agent. 294 
 The isoflavone enriched extract greatly inhibited the formation of non-295 
fluorescent (Fig. 3) and fluorescent (Fig. 4) AGEs. The characteristic fluorescence 296 
spectrum of AGEs changed in samples containing the isoflavone extract. This is 297 
attributed to the absorption of the AGE glycophore, formed by the linking of protein 298 
and glucose molecules, in accordance with data obtained by Rondeau et al.
28
 These 299 
results agree with those obtained by Wang et al.
19
 using ferulic acid and feruloyl-300 
oligosaccharides as glycation inhibitors. They obtained a progressive decrease in 301 
fluorescence with increasing concentration of inhibitor. 302 
 The formation of CML and fluorescent AGEs like pentosidine is catalysed under 303 
oxidative conditions. In agreement with this, our data seem to indicate that although part 304 
of the AGEs formed in our particular system can come from oxidative sugar 305 
degradation (CML), they are also being generated from early MR products (Heyns 306 
rearrangement products). 307 
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 The primary structure of isoflavones is three benzene rings with one or more 308 
hydroxyl groups; this structure is the key factor that determines their anti-oxidant 309 
activity. Matsuda et al.
7
 examined several flavonoids for inhibitory activity towards 310 
AGE formation. Compared to the well-known AGE inhibitor, aminoguanidine, 311 
flavonoids showed stronger inhibitory effects. Nevertheless, isoflavones only weakly 312 
inhibited AGEs formation (by 25-46% at 200 µM). In the current study, the isoflavones 313 
enriched extract showed strong inhibitory activity, therefore, the antioxidative effects of 314 
isoflavones are apparently, at least in part, involved in AGEs inhibition mechanisms. 315 
 In the present in vitro study, we demonstrate that a mixture of isoflavones (soy 316 
isoflavone-rich extract) is an effective inhibitor of the formation of early MR products 317 
and AGEs. Our data suggest that the formation of early MR products may be inhibited 318 
by conjugation of isoflavones to the active site of glycation, while AGEs formation may 319 
be modulated by trapping of dicarbonyl intermediates and oxygen radical species. In 320 
addition, our results suggest that a soy isoflavone-rich extract might be useful for the 321 
generation of particular glycoconjugates with improved functional properties. Further 322 
research should be performed to confirm this hypothesis. Phytochemomics
29
 may be an 323 
appropriate tool for the generation of this necessary knowledge. 324 
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Figure 1. Free amino group content of unheated and heated protein (control), glycation 411 
model (soy glycinin protein-fructose) and isoflavones inhibition model in 0.2% KOH 412 
solution in presence of genistin, genistein and soy isoflavone-rich extract (60ºC for 60 413 
min). Data are expressed as a percentage of the control (unheated protein) value. Data 414 
are means of triplicate analyses. Error bars denote the relative standard deviation. 415 
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Figure 2. Sugar content of unheated and heated protein (control), glycation model (soy 420 
glycinin protein-fructose) and isoflavones inhibition model in 0.2% KOH solution in 421 
presence of genistin, genistein and soy isoflavone-rich extract (60ºC for 60 min). Data 422 
are expressed as µg sugar/100 mg protein. Data are means of triplicate analyses. Error 423 
bars denote the relative standard deviation. Values with different letters are significantly 424 
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Figure 3. Content of protein-bound CML in unheated and heated proteins (control), 429 
glycation model (soy glycinin protein-fructose) and isoflavones inhibition model in 430 
0.2% KOH solution in presence of genistin, genistein and soy isoflavone-rich extract 431 
(60ºC for 60 min). Data are expressed in millimol of CML/mol of lysine. Values are 432 
means of triplicate analyses. Data are means of triplicate analyses. Error bars denote the 433 
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Figure 4. Fluorescence spectra of glycation model systems in 0.2% KOH solution in 439 
presence of genistin, genistein and soy isoflavone-rich extract. 440 
 441 
 442 
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E-mail: mdolores.delcastillo@csic.es. 
Page 23 of 23 Food & Function
